A Study to Check if Agnikarma Treatment Gives Extra Relief in Sciatica

A randomized control trial to evalute the effect of agnikarma as an add-on therapy in gridhrasi - AGRA-GRID

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/0102211

Enrollment

100

Registered

2026-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Basti Arha. Gender-Both(Male and Female) Age- 30 to 60yrs. Patients with textual signs and symptoms of Gridhrasi as explained in Charaka Samhita VataVyadhi Chikitsa Adhyaya 28/56

Exclusion criteria

Exclusion criteria: Any other systemic conditions which may interfere the treatment- K/C/O - TB, HIV, CA. Any other Structural deformities. Trauma, Fracture

Design outcomes

Primary

Measure	Time frame
To compare efficacy of Vaitarana Basti with Agnikarma and Vaitarana Basti without Agnikarma for 15 days in Gridhrasi.Timepoint: 15 days	—

Secondary

Measure	Time frame
To study the Add-on effect of Agnikarma in Gridhrasi. 2) To Study the effect of Vaitarana Basti in Gridhrasi. Timepoint: 15 days	—

Countries

India

Contacts

Public ContactDr Akshada Arun Gujar

Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune

drmayagokhale@gmail.com9422323285

Outcome results